25-MAY-2024 6:10

ERLYTX ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S2012-Small Cell NEC, Stg IV, Combo Chemo +/- Atezo 1 Y 1 Platinum/Etoposide + Atezo Induction + Maintenance 189 18 15 9 3 0 0 06/28/2022 179 71
        2 Platinum/Etoposide + Atezo Induction   14 9 3 2 1 1      
        3 Platinum/Etoposide Only   14 10 6 4 1 0      
            46 34 18 9 2 1      
 
  EAY191-S3-ComboMATCH: Adv Solid Tumors, Pac+Ipatasertib 1 Y 1 Paclitaxel + Ipatasertib 33 1 1 0 0 0 0 09/22/2023 180 61
            1 1 0 0 0 0      
 
Yes A071401-Prog Meningiomas,SMO/AKT/NF2 Inhib 0 E Total Registrations   44 2 1 0 0 0 02/22/2016 244 90
            44 2 1 0 0 0      
 
    1 E Total Registrations   8 0 0 0 0 0 02/22/2016    
            8 0 0 0 0 0      
 
  EAY191A3-ComboMATCH-RAS-Mutant, All Stg, Palbo+Benim 1 E Total Registrations   2 2 2 0 0 0 02/08/2024 78 33
            2 2 2 0 0 0      
 
No AGCT1531-Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult 1 E Total Registrations   2 1 0 0 0 0 10/07/2021 176 116
            2 1 0 0 0 0      
 
  EAY191-ComboMATCH 1 E Total Registrations   8 8 5 2 0 0 08/03/2023 252 107
            8 8 5 2 0 0      
 
  EAY191E4-ComboMATCH-Pr. Tax-Tx Tumors, Pac+Nilotinib 1 E Total Registrations   3 3 0 0 0 0 08/17/2023 133 57
            3 3 0 0 0 0      
 

25-MAY-2024 6:10

ERLYTX Open Studies with No Registrations

Study Registration/Phase Open Date # of
ACT.
INSTs
# of
CURR
IRBs
AGCT1531 Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult 2 Late Randomization Callback 08-May-17 176 116
EAY191 ComboMATCH 2 Re-Screening 06-Mar-23 252 107
EAY191A3 ComboMATCH-RAS-Mutant, All Stg, Palbo+Benim 2 Cohort Migration 15-Nov-23 78 33